Phospholipogenic Pharmaceuticals Are Associated with a Higher Incidence of Histological Findings than Nonphospholipogenic Pharmaceuticals in Preclinical Toxicology Studies

Por Barone, Linda R., Boyer, Scott, Damewood, James R., Fikes, James, Ciaccio, Paul J.
Publicado em 2012

Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4(+) and CD8(+) T Cells

Por Sabins, Nina C., Harman, Benjamin C., Barone, Linda R., Shen, Shixue, Santulli-Marotto, Sandra
Publicado no Front Immunol (2016)

Relationship of Pleconaril Susceptibility and Clinical Outcomes in Treatment of Common Colds Caused by Rhinoviruses

Por Pevear, Daniel C., Hayden, Frederick G., Demenczuk, Tina M., Barone, Linda R., McKinlay, Mark A., Collett, Marc S.
Publicado em 2005

An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge

Por Yang, Guang, Pevear, Daniel C., Davies, Marc H., Collett, Marc S., Bailey, Tom, Rippen, Susan, Barone, Linda, Burns, Chris, Rhodes, Gerry, Tohan, Sanjeev, Huggins, John W., Baker, Robert O., Buller, R. L. Mark, Touchette, Erin, Waller, Kem, Schriewer, Jill, Neyts, Johan, DeClercq, Erik, Jones, Kevin, Hruby, Dennis, Jordan, Robert
Publicado em 2005